Search results
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
Insider Monkey via Yahoo Finance· 15 hours agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Sanofi SA...
Regeneron, Sanofi Get Expanded FDA OK for Kevzara in Polyarticular Juvenile Idiopathic Arthritis
Morningstar· 21 hours agoBy Colin Kellaher Regeneron Pharmaceuticals and Sanofi have won expanded Food and Drug Administration approval of their arthritis drug Kevzara for certain ...
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 14 hours agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a...
XML Financial LLC Sells 5,445 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 1 day agoXML Financial LLC trimmed its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 54.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor ...
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 20 hours agoCharles River and Sanofi are collaborating to pilot VCGs in non-clinical toxicology programs and...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 23 hours agoThings have turned around for Novavax, though, thanks to a partnership with Sanofi. The French ...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 5 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
Health Care Roundup: Market Talk
The Wall Street Journal· 10 hours agoSanofi and Pfizer—who both temporarily held rights for the drug—are understood to have recently made U.S. case settlements...promise in a late-stage...
My Novavax stock price forecast was correct: what next now? | Invezz
Invezz· 6 days agoNovavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the...
Managing Change In Vaccine Production With All Stakeholders
BioresearchOnline· 1 hour agoBalancing stakeholder expectations and opinions, and sometimes mitigating disagreements, during a...